Waltham, Massachusetts Friday, November 15, 2024, 15:00 Hrs [IST] ...

Aileron Therapeutics' Phase 1b trial shows LTI-03 improved biomarkers and reduced SPD levels, indicating the potential to ...

High-dose LTI-03 (5 mg BID), a Caveolin-1 related peptide, reduced expression of multiple profibrotic proteins in both ...

Aileron Therapeutics (ALRN) announced positive topline data from Cohort 2 of its Phase 1b clinical trial evaluating the safety and tolerability ...

DelveInsight’s, “Interstitial Lung Diseases Pipeline Insight 2024” report provides comprehensive insights about 120+ ...

Idiopathic pulmonary fibrosis is a chronic, progressive, incurable lung disease, leading to irreversible lung tissue ...

Metastatic lung cancer is cancer that has spread (metastasized) from the lungs to other parts of the body, such as the liver or brain. While early-stage lung cancer is often asymptomatic (without ...

and lung diseases. Yet fibrosis of these organs remains a deadly disease with limited treatments. "The crosstalk between the immune system and fibroblasts is even more complex than we expected ...

Slowing or stopping fibrosis can help treat heart, liver, kidney, and lung diseases ... out exactly how immune cells trigger scar-forming fibroblasts to become activated and cause fibrosis ...

23 in the journal Nature. Studying human tissue samples as part of the new study, the researchers identified a type of fibroblast cell in the heart as the main culprit responsible for the ...